DK3750538T3 - Ikke-hormonelle fremgangsmåder til mandlig prævention omfattende (r)-silodosin - Google Patents

Ikke-hormonelle fremgangsmåder til mandlig prævention omfattende (r)-silodosin Download PDF

Info

Publication number
DK3750538T3
DK3750538T3 DK20182691.4T DK20182691T DK3750538T3 DK 3750538 T3 DK3750538 T3 DK 3750538T3 DK 20182691 T DK20182691 T DK 20182691T DK 3750538 T3 DK3750538 T3 DK 3750538T3
Authority
DK
Denmark
Prior art keywords
silodosine
male contraception
hormonal methods
contraception including
hormonal
Prior art date
Application number
DK20182691.4T
Other languages
Danish (da)
English (en)
Inventor
Philippe Perrin
Glaoui Guillaume El
Glaoui Mehdi El
Véronique Agathon-Meriau
Stéphane Droupy
Original Assignee
Pharmajor Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmajor Int filed Critical Pharmajor Int
Application granted granted Critical
Publication of DK3750538T3 publication Critical patent/DK3750538T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/4045Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16Masculine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
DK20182691.4T 2018-03-23 2019-03-22 Ikke-hormonelle fremgangsmåder til mandlig prævention omfattende (r)-silodosin DK3750538T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862763129P 2018-03-23 2018-03-23
EP18305328 2018-03-23
EP19714150.0A EP3562485B8 (en) 2018-03-23 2019-03-22 Non-hormonal compositions and methods for male contraception comprising (r)-silodosin

Publications (1)

Publication Number Publication Date
DK3750538T3 true DK3750538T3 (da) 2024-09-23

Family

ID=65955198

Family Applications (2)

Application Number Title Priority Date Filing Date
DK20182691.4T DK3750538T3 (da) 2018-03-23 2019-03-22 Ikke-hormonelle fremgangsmåder til mandlig prævention omfattende (r)-silodosin
DK19714150.0T DK3562485T3 (da) 2018-03-23 2019-03-22 Ikke-hormonale sammensætninger og fremgangsmåder til mandlig kontraception omfattende (r)-silodosin

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK19714150.0T DK3562485T3 (da) 2018-03-23 2019-03-22 Ikke-hormonale sammensætninger og fremgangsmåder til mandlig kontraception omfattende (r)-silodosin

Country Status (19)

Country Link
US (3) US10912762B2 (https=)
EP (2) EP3562485B8 (https=)
JP (1) JP7270901B2 (https=)
KR (1) KR102496504B1 (https=)
CN (1) CN112074269A (https=)
AU (1) AU2019237228B2 (https=)
BR (1) BR112020018925A2 (https=)
CA (1) CA3094016C (https=)
DK (2) DK3750538T3 (https=)
ES (2) ES2989170T3 (https=)
FI (1) FI3750538T3 (https=)
IL (1) IL277372B2 (https=)
MA (1) MA53626B1 (https=)
MX (1) MX2020009937A (https=)
PL (2) PL3750538T3 (https=)
PT (1) PT3562485T (https=)
SG (1) SG11202008794TA (https=)
UA (1) UA128502C2 (https=)
WO (1) WO2019180217A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3750538T3 (pl) * 2018-03-23 2024-11-25 Pharmajor International Niehormonalne sposoby męskiej antykoncepcji obejmujące (r) -sylodosynę
AU2023384256A1 (en) * 2022-11-23 2025-03-20 Pharmajor Incorporated Modified-release silodosin compositions and use thereof in methods for male contraception

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1091276A (en) 1911-12-09 1914-03-24 Basf Ag Producing unsaturated terpene hydrocarbons.
US4210644A (en) 1978-02-23 1980-07-01 The Johns Hopkins University Male contraception
DE4308406C1 (de) 1993-03-12 1994-06-16 Jenapharm Gmbh Kombinationspräparat zur Kontrazeption
HUP0300128A3 (en) 2000-02-15 2004-03-29 Schering Ag Male contraceptive composition comprising norethisterone and its use
FR2861990B1 (fr) * 2003-11-10 2006-02-10 Nouveaux Produits Pharma Comprimes faiblement doses a reseau de polymeres
US20090186896A1 (en) * 2005-09-29 2009-07-23 Bayer Healthcare Ag PDE Inhibitors and Combinations Thereof for the Treatment of Urological Disorders
CN101316934A (zh) * 2005-09-29 2008-12-03 拜耳医药保健股份公司 用于治疗泌尿系统疾病的pde抑制剂及其组合
MX2009003737A (es) * 2006-10-05 2009-06-16 Panacea Biotec Ltd Composicion inyectable en deposito y su procedimiento de preparacion.
GB0700893D0 (en) 2007-01-17 2007-02-21 King S College London Male contraceptive
US20080242717A1 (en) 2007-02-28 2008-10-02 Fumiyasu Sato Methods for treating benign prostatic hyperplasia
US20120184591A1 (en) * 2011-01-13 2012-07-19 Watson Pharmaceuticals, Inc. Methods for treating prostatitis
CN102283816B (zh) 2011-08-05 2013-09-11 北京海步国际医药科技发展有限公司 西洛多辛缓释片剂及其制备方法
WO2014118606A2 (en) * 2013-01-29 2014-08-07 Alembic Pharmaceuticals Limited A novel process for the preparation of silodosin
JPWO2016051782A1 (ja) 2014-09-30 2017-07-13 キッセイ薬品工業株式会社 苦味を有する薬剤の苦味をマスキングした経口投与製剤
US20170049834A1 (en) * 2015-08-18 2017-02-23 Golden Biotechnology Corporation Benign prostatic hyperplasia add-on therapy
PL3750538T3 (pl) * 2018-03-23 2024-11-25 Pharmajor International Niehormonalne sposoby męskiej antykoncepcji obejmujące (r) -sylodosynę

Also Published As

Publication number Publication date
EP3562485B1 (en) 2020-07-01
JP7270901B2 (ja) 2023-05-11
US11951095B2 (en) 2024-04-09
BR112020018925A2 (pt) 2020-12-29
IL277372B1 (en) 2023-05-01
MA53626B1 (fr) 2024-09-30
EP3750538B1 (en) 2024-08-14
JP2021518438A (ja) 2021-08-02
ES2813084T3 (es) 2021-03-22
IL277372A (en) 2020-11-30
PL3750538T3 (pl) 2024-11-25
US11583518B2 (en) 2023-02-21
PL3562485T3 (pl) 2020-11-16
AU2019237228A1 (en) 2020-10-01
EP3750538A1 (en) 2020-12-16
UA128502C2 (uk) 2024-07-31
US20210113526A1 (en) 2021-04-22
WO2019180217A1 (en) 2019-09-26
KR102496504B1 (ko) 2023-02-06
CA3094016A1 (en) 2019-09-26
US20230145374A1 (en) 2023-05-11
ES2989170T3 (es) 2024-11-25
PT3562485T (pt) 2020-08-27
IL277372B2 (en) 2023-09-01
CN112074269A (zh) 2020-12-11
EP3562485A1 (en) 2019-11-06
RU2020134408A (ru) 2022-04-29
FI3750538T3 (fi) 2024-09-24
MA53626A (fr) 2022-03-09
US10912762B2 (en) 2021-02-09
AU2019237228B2 (en) 2023-06-08
US20190290615A1 (en) 2019-09-26
SG11202008794TA (en) 2020-10-29
NZ767741A (en) 2024-11-29
MX2020009937A (es) 2022-09-30
RU2020134408A3 (https=) 2022-04-29
KR20200135978A (ko) 2020-12-04
DK3562485T3 (da) 2020-08-24
CA3094016C (en) 2023-10-10
EP3562485B8 (en) 2020-08-19

Similar Documents

Publication Publication Date Title
MA50205A (fr) Formulation de nicotine
EP3813751A4 (en) Dressing
LT3728870T (lt) Plokščių rinkinys
DK3668851T3 (da) Fremgangsmåde til fremstilling af thiocarbonater
EP3509581A4 (en) FORMULATIONS OF (R
LT4331584T (lt) Lanifibranoro deuterintų darinių terapietiniai naudojimai
SI3565542T1 (sl) Polimorfne oblike RAD1901-2HCL
IL272851A (en) Methods of using dipivefrin
DK3574135T3 (da) Fremgangsmåde og formulering til fremstilling af ligninfibre
EP3827689A4 (en) SHOE INSOLE
PL3457851T3 (pl) Pochodne sobetiromu
DK3523274T3 (da) Formuleringer til indgivelse af eflornithin
PL3625224T3 (pl) Pochodne n-podstawionego indolu
IL282813A (en) Antibody formulation
LT3661562T (lt) Cys-mab konjugavimo būdas
DK3578562T3 (da) L-valinatamidbenzoxaborolderivater til behandling af parasitiske sygdomme
EP3608576A4 (en) NEW TYPE OF FAST PIPE CONNECTION
DK3678644T3 (da) Formuleringer af copanlisib
DK3442944T3 (da) Fremgangsmåde til fremstillingen af 4-aminoindanderivater og relaterede aminoindanamider
SI3749673T1 (sl) Kristalinična oblika biktegravir natrija
HRP20251697T1 (hr) Kristalni oblik n-butildeoksigalaktonojirimicina
DK3750538T3 (da) Ikke-hormonelle fremgangsmåder til mandlig prævention omfattende (r)-silodosin
FR3024947B1 (fr) Structure de joint coupe-feu en boudin
DK3544068T3 (da) Fremgangsmåde til fremstilling af termoelektriske mikrokølere
DK3652187T3 (da) Forbedret fremgangsmåde til fremstilling af imetelstat